Dynamics of success and failure in phage and antibiotic therapy in experimental infections

<p>Abstract</p> <p>Background</p> <p>In 1982 Smith and Huggins showed that bacteriophages could be at least as effective as antibiotics in preventing mortality from experimental infections with a capsulated E. coli (K1) in mice. Phages that required the K1 capsule for i...

Full description

Bibliographic Details
Main Authors: Walker Nina, DeRouin Terry, Levin Bruce R, Bull J J, Bloch Craig A
Format: Article
Language:English
Published: BMC 2002-11-01
Series:BMC Microbiology
Online Access:http://www.biomedcentral.com/1471-2180/2/35
id doaj-4f1415cfdb9343e4902942519ec610ec
record_format Article
spelling doaj-4f1415cfdb9343e4902942519ec610ec2020-11-24T23:44:03ZengBMCBMC Microbiology1471-21802002-11-01213510.1186/1471-2180-2-35Dynamics of success and failure in phage and antibiotic therapy in experimental infectionsWalker NinaDeRouin TerryLevin Bruce RBull J JBloch Craig A<p>Abstract</p> <p>Background</p> <p>In 1982 Smith and Huggins showed that bacteriophages could be at least as effective as antibiotics in preventing mortality from experimental infections with a capsulated E. coli (K1) in mice. Phages that required the K1 capsule for infection were more effective than phages that did not require this capsule, but the efficacies of phages and antibiotics in preventing mortality both declined with time between infection and treatment, becoming virtually ineffective within 16 hours.</p> <p>Results</p> <p>We develop quantitative microbiological procedures that (1) explore the in vivo processes responsible for the efficacy of phage and antibiotic treatment protocols in experimental infections (the Resistance Competition Assay, or RCA), and (2) survey the therapeutic potential of phages in vitro (the Phage Replication Assay or PRA). We illustrate the application and utility of these methods in a repetition of Smith and Huggins' experiments, using the E. coli K1 mouse thigh infection model, and applying treatments of phages or streptomycin.</p> <p>Conclusions</p> <p>1) The Smith and Huggins phage and antibiotic therapy results are quantitatively and qualitatively robust. (2) Our RCA values reflect the microbiological efficacies of the different phages and of streptomycin in preventing mortality, and reflect the decline in their efficacy with a delay in treatment. These results show specifically that bacteria become refractory to treatment over the term of infection. (3) The K1-specific and non-specific phages had similar replication rates on bacteria grown in broth (based on the PRA), but the K1-specific phage had markedly greater replication rates in mouse serum.</p> http://www.biomedcentral.com/1471-2180/2/35
collection DOAJ
language English
format Article
sources DOAJ
author Walker Nina
DeRouin Terry
Levin Bruce R
Bull J J
Bloch Craig A
spellingShingle Walker Nina
DeRouin Terry
Levin Bruce R
Bull J J
Bloch Craig A
Dynamics of success and failure in phage and antibiotic therapy in experimental infections
BMC Microbiology
author_facet Walker Nina
DeRouin Terry
Levin Bruce R
Bull J J
Bloch Craig A
author_sort Walker Nina
title Dynamics of success and failure in phage and antibiotic therapy in experimental infections
title_short Dynamics of success and failure in phage and antibiotic therapy in experimental infections
title_full Dynamics of success and failure in phage and antibiotic therapy in experimental infections
title_fullStr Dynamics of success and failure in phage and antibiotic therapy in experimental infections
title_full_unstemmed Dynamics of success and failure in phage and antibiotic therapy in experimental infections
title_sort dynamics of success and failure in phage and antibiotic therapy in experimental infections
publisher BMC
series BMC Microbiology
issn 1471-2180
publishDate 2002-11-01
description <p>Abstract</p> <p>Background</p> <p>In 1982 Smith and Huggins showed that bacteriophages could be at least as effective as antibiotics in preventing mortality from experimental infections with a capsulated E. coli (K1) in mice. Phages that required the K1 capsule for infection were more effective than phages that did not require this capsule, but the efficacies of phages and antibiotics in preventing mortality both declined with time between infection and treatment, becoming virtually ineffective within 16 hours.</p> <p>Results</p> <p>We develop quantitative microbiological procedures that (1) explore the in vivo processes responsible for the efficacy of phage and antibiotic treatment protocols in experimental infections (the Resistance Competition Assay, or RCA), and (2) survey the therapeutic potential of phages in vitro (the Phage Replication Assay or PRA). We illustrate the application and utility of these methods in a repetition of Smith and Huggins' experiments, using the E. coli K1 mouse thigh infection model, and applying treatments of phages or streptomycin.</p> <p>Conclusions</p> <p>1) The Smith and Huggins phage and antibiotic therapy results are quantitatively and qualitatively robust. (2) Our RCA values reflect the microbiological efficacies of the different phages and of streptomycin in preventing mortality, and reflect the decline in their efficacy with a delay in treatment. These results show specifically that bacteria become refractory to treatment over the term of infection. (3) The K1-specific and non-specific phages had similar replication rates on bacteria grown in broth (based on the PRA), but the K1-specific phage had markedly greater replication rates in mouse serum.</p>
url http://www.biomedcentral.com/1471-2180/2/35
work_keys_str_mv AT walkernina dynamicsofsuccessandfailureinphageandantibiotictherapyinexperimentalinfections
AT derouinterry dynamicsofsuccessandfailureinphageandantibiotictherapyinexperimentalinfections
AT levinbrucer dynamicsofsuccessandfailureinphageandantibiotictherapyinexperimentalinfections
AT bulljj dynamicsofsuccessandfailureinphageandantibiotictherapyinexperimentalinfections
AT blochcraiga dynamicsofsuccessandfailureinphageandantibiotictherapyinexperimentalinfections
_version_ 1725500270479147008